New Delhi, Feb. 28 -- Sanofi India declared their Q4 results on 27 Feb, 2025. The topline increased by 9.74% compared to the previous year, but the profit saw a significant decline of 33.7%, amounting to Rs.91.3 crore. The revenue for the quarter stood at Rs.514.9 crore.

In comparison to the previous quarter, revenue experienced a slight decline of 1.74%, while profit showed an increase of 11.07%. This indicates fluctuations in performance amidst evolving market conditions.

The Selling, general & administrative expenses saw a notable decrease, declining by 5.11% quarter-on-quarter and by 25.79% year-on-year. Such reductions could contribute positively to future profitability as the company manages its operational costs.

Furthermore, th...